Article Versions Notes

Ershova ES, Veiko NN, Nikitina SG, Balakireva EE, Martynov AV, Chudakova JM, Shmarina GV, Kostyuk SE, Salimova NA, Veiko RV, et al. Ribosomal DNA Abundance in the Patient’s Genome as a Feasible Marker in Differential Diagnostics of Autism and Childhood-Onset Schizophrenia. Journal of Personalized Medicine. 2022; 12(11):1796. https://doi.org/10.3390/jpm12111796

Ershova, Elizaveta S., Natalia N. Veiko, Svetlana G. Nikitina, Elena E. Balakireva, Andrey V. Martynov, Julia M. Chudakova, Galina V. Shmarina, Svetlana E. Kostyuk, Nataliya A. Salimova, Roman V. Veiko, and et al. 2022. "Ribosomal DNA Abundance in the Patient’s Genome as a Feasible Marker in Differential Diagnostics of Autism and Childhood-Onset Schizophrenia" Journal of Personalized Medicine 12, no. 11: 1796. https://doi.org/10.3390/jpm12111796

Ershova, E. S., Veiko, N. N., Nikitina, S. G., Balakireva, E. E., Martynov, A. V., Chudakova, J. M., Shmarina, G. V., Kostyuk, S. E., Salimova, N. A., Veiko, R. V., Porokhovnik, L. N., Asanov, A. Y., Izhevskaia, V. L., Kutsev, S. I., Simashkova, N. V., & Kostyuk, S. V. (2022). Ribosomal DNA Abundance in the Patient’s Genome as a Feasible Marker in Differential Diagnostics of Autism and Childhood-Onset Schizophrenia. Journal of Personalized Medicine, 12(11), 1796. https://doi.org/10.3390/jpm12111796